Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

C WorldWide Medical 2A Fonds 1101361 / LU0121135528

2’287.84 NOK
25.75 NOK
1.14 %
9.1.2025
NAV

Nettoinventarwert (NAV)

2’287.84 NOK 25.75 NOK 1.14 %
Vortag 2’262.09 NOK Datum 09.01.2025

C WorldWide Medical 2A Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Stellar ETP CH1109575535 354.75%
21Shares Ripple XRP ETP CH0454664043 334.40%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Algorand ETP CH1146882316 196.18%
21Shares Cardano ETP CH1102728750 178.10%
21Shares Sui Staking ETP CH1360612159 119.60%
21Shares Injective Staking ETP CH1360612134 14.29%
21Shares Immutable ETP CH1360612142 -8.25%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 429.63%
21Shares Stellar ETP CH1109575535 379.12%
21Shares Aave ETP CH1135202120 254.88%
21Shares Algorand ETP CH1146882316 170.06%
21Shares Cardano ETP CH1102728750 161.84%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 297.92%
21Shares Stellar ETP CH1109575535 244.49%
21Shares Aave ETP CH1135202120 198.89%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 168.42%
21Shares Binance BNB ETP CH0496454155 124.66%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’444.52%
21Shares Ripple XRP ETP CH0454664043 547.74%
21Shares Bitcoin Core ETP CH1199067674 464.56%
21Shares Bitcoin ETP CH0454664001 450.29%
21Shares Stellar ETP CH1109575535 439.59%

Fundamentaldaten

Valor 1101361
ISIN LU0121135528
Emittent C WorldWide Fund Management
Aufgelegt in Luxembourg
Auflagedatum 18.12.2000
Kategorie Branchen: Gesundheitswesen
Währung NOK
Volumen 761’072’428.05
Depotbank Bank of New York Mellon (Luxembourg) S.A.
Geschäftsjahresende 31.12.
Berichtsstand 13.12.2024

Anlagepolitik

So investiert der C WorldWide Medical 2A Fonds: Carnegie Medical is a Sub Fund of the CARNEGIE FUND, an unincorporated open-ended collective investment fund registered in Luxembourg under Part 1 of the Law of December 20, 2002. The investment objective of the Sub Fund is to achieve long-term capital growth through global investment in equities of companies operating in the pharmaceutical, biotechnology and medical technology sectors. The Sub Fund will focus particularly on large-cap companies which will account for at least 75% of the Sub Fund?s value and also on small-cap companies which may represent up to 25% of the Sub Fund?s value.

ETP Performance: C WorldWide Medical 2A Fonds

Performance 1 Jahr
14.00
Performance 2 Jahre
23.18
Performance 3 Jahre
35.25
Performance 5 Jahre -
Performance 10 Jahre -